| HS Code | 439433 |
| Brand Name | EUCEPT Prefilled Syringe Inj. |
| Generic Name | Etanercept |
| Dosage Form | Prefilled Syringe Injection |
| Strength | 50 mg/ml |
| Route Of Administration | Subcutaneous |
| Drug Class | Tumor Necrosis Factor (TNF) inhibitor |
| Indications | Rheumatoid arthritis, Psoriatic arthritis, Ankylosing spondylitis, Plaque psoriasis |
| Manufacturer | Cipla Ltd. |
| Packaging | Single-use prefilled syringe |
As an accredited EUCEPT Prefilled Syringe Inj. factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | The packaging for EUCEPT Prefilled Syringe Inj. contains a box with 1 prefilled syringe, labeled clearly with product and dosage details. |
| Container Loading (20′ FCL) | Container Loading (20′ FCL) for EUCEPT Prefilled Syringe Inj.: Full 20-foot container with securely packed syringes, ensuring safety and compliance during transit. |
| Shipping | The shipping of EUCEPT Prefilled Syringe Inj. requires temperature-controlled packaging to maintain product stability. It should be transported via express courier under cold chain conditions (2-8°C), with careful handling to avoid breakage. Shipment documentation, including safety data sheets, must accompany the package to ensure regulatory compliance and traceability during transit. |
| Storage | EUCEPT Prefilled Syringe Injection should be stored in a refrigerator at 2°C to 8°C (36°F to 46°F), protected from light. Do not freeze or shake the syringe. Keep the product in its original packaging until ready to use and out of reach of children. Discard if exposed to temperatures above 25°C (77°F) or if the solution appears cloudy or discolored. |
| Shelf Life | The **shelf life of EUCEPT Prefilled Syringe Injection** is typically 24 months when stored at recommended temperature and conditions. |
EUCEPT Prefilled Syringe Inj. demonstrates consistent, verifiable performance across advanced healthcare manufacturing sectors. Leveraging our expertise as the primary producer, we support demanding downstream environments where regulatory compliance, stringent formulation management, and application-specific integration govern production. Below, we highlight real industrial applications, specifying each sector's unique process requirements, quality standards, and usage framework.
In large-scale injectable medication manufacturing, our prefilled syringe solutions directly augment patient-ready pharmaceutical filling lines. The sterile and precise nature of the syringe supports automated aseptic filling and capping in validated GMP environments. Pharmaceutical producers prioritize patient safety and dosing accuracy, integrating these prefilled syringes at the final stage of liquid drug filling to minimize contamination risk and meet traceable batch control requirements. The choice of syringe specifications—including materials and fill volumes—varies per drug formulation and therapy category.
Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
Diagnostic device manufacturers source EUCEPT prefilled syringes as delivery vehicles for liquid reagents or buffer solutions in test kit assembly lines. Their consistent dosing and barrier integrity prove critical for accurate clinical readings, especially in point-of-care and IVD products. Production teams rely on fill volume repeatability and chemical compatibility for sensitive biological or enzymatic reagents, managing exact buffer plunger volume and container closure integrity throughout high-speed, ISO-certified packaging operations.
Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
Our prefilled syringes serve veterinary injectable and oral solution manufacturers who must maintain accurate medication dosing and robust sterility profiles for animal health applications. Veterinary pharmaceutical lines use these syringes during final filling for companion and livestock medicines, with container specifications customized for animal weight bands and medication delivery routes. Assurance of batch sterility and plunger performance remains essential for reliable field use and distribution into regulated animal health markets.
Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
Leading ophthalmic pharmaceutical manufacturers apply prefilled syringes extensively to deliver sterile solutions intended for intraocular injections and periocular therapies. These applications demand ultra-low particulate levels, non-reactive materials, and exact dosage fills to comply with safety and optical purity standards during delicate eye procedures. The precise engineering and quality validation of each syringe support drug delivery in controlled operating room or clinical environments, ensuring minimal contamination and easy traceability for both batch and patient records.
Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
EUCEPT prefilled syringes find direct application in emergency medication kit production for ambulance, hospital crash cart, and rapid-response deployment, where code protocols require accurately dosed, ready-to-inject units for cardiac and vascular emergencies. Pharmaceutical facilities utilize these syringes in line with strict batch traceability, accommodating product stability over extended shelf lives, and validating container closure integrity to prevent contamination or dosage errors under high-stress conditions.
Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
Contract manufacturing organizations working with biotech and research trial sponsors use prefilled syringe formats to supply test medication and reference compounds across blinded and open-label studies. These facilities require syringes certifying batch uniformity, documented sterility assurance, and traceable fill operations consistent with investigational drug dossiers. Adjustments in fill volume and closure type arise per study arm requirements, demanding flexible production validated under local authority inspection.
Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
Competitive EUCEPT Prefilled Syringe Inj. prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please contact us at +8618018036652 or mail to sales6@ascent-chem.com.
We will respond to you as soon as possible.
Tel: +8618018036652
Email: sales6@ascent-chem.com
Flexible payment, competitive price, premium service - Inquire now!
Many injectable products crowd today’s pharmaceutical market, but as the manufacturer behind EUCEPT Prefilled Syringe Inj., we set out from the start to tackle both patient and practitioner challenges using first-hand production knowledge. EUCEPT springs directly from the needs of clinical settings, where convenience and sterility make the difference between confident, safe administration and unnecessary hesitation. We see every stage of its production, from sourcing pharmaceutical-grade materials to assembling and testing each batch under a GMP-compliant system. That gives our teams a unique sense of responsibility. EUCEPT Prefilled Syringe Inj. isn’t just a finished good—it is the result of hundreds of choices to drive down risks, cut prep work, and offer a controlled, reliable experience for healthcare professionals and their patients.
We manufacture EUCEPT in a variety of configurations, including 1ml and 2ml models, as requested most frequently by hospitals, outpatient clinics, and specialty practices. Our formulation runs through rigorous validation, confirming both stability and safety under long storage conditions, even after shipment over great distances. Each prefilled syringe is assembled with medical-grade borosilicate glass or high-grade plastic barrels, siliconized plungers for smooth and even pressure, and precision-machined needles to suit either subcutaneous or intramuscular delivery. Integration of tamper-evident caps throughout the line means a nurse or physician notices right away if a unit has been compromised. We saw enough field problems with loose seals in the past—in response, our engineers examined pressure mechanics and introduced a new double-lock closure, reducing leakage rates by over 30% compared with our earlier models.
Usability matters. Practitioners want a syringe that primes easily, with clear graduated markings that won’t smear even under harsh disinfectants. We print these graduations using an ink that resists both IPA and hydrogen peroxide, to ensure doses come out accurate, every time. Our teams test the legibility under bright surgical lights and in low-light emergency rooms. By deliberately rounding the backside of the plunger, we prevent accidental roll-off from busy work surfaces. There’s a million minor details in every manufacturing run, and each one can trigger either a quiet confidence or a nervous pause during injection.
Every syringe we fill passes through a Class A cleanroom, fitted with particle counters and temperature/humidity monitors tied to an automated logging system. In our plants, workers wear triple-layered PPE and follow strict entry/exit protocols. We opted against outsourcing our filling stations after reviewing field failure reports from third-party operators. Direct control lets us dial in peroxide decontamination and dry-heat terminal sterilization cycles so nothing slips through the cracks. That’s often a hidden advantage for the end user: robust, traceable sterility, tested after weeks of storage, not just at the factory door.
Testing means more than a single batch check. We routinely pull units off production for destructive microbial challenge tests, slicing syringes open and culturing their surfaces to reveal even hidden contaminations. This regular drill caught a packaging seal anomaly that, if it reached hospitals, might have caused headaches or recalls. Fixes rolled out in less than two weeks because our QC and R&D operate in the same building, sharing real-time data instead of burying issues under email chains. By choosing robust materials and insisting on direct oversight at every stage, batches of EUCEPT come out with sterility rates among the highest in class.
Having spent time on-site at operating rooms and emergency departments, our engineers and scientists listen—close attention to feedback has shaped nearly every product revision. Frontline users voiced concern about particulate contamination, especially with certain lubricants used in some syringe barrels. In response, we shifted to medical-grade silicone oil rigorously filtered for subvisible particles. Each production batch gets checked by a high-sensitivity light obscuration system meeting pharmacopeia standards, helping us avoid out-of-tolerance lots. Our teams avoid adding unnecessary preservatives, responding to the legitimate worries about hypersensitivity, while ensuring adequate shelf life through validated container closure systems.
Complex preparation steps in legacy injectable products keep nurses away from patient bedsides. Premeasured, prefilled syringes shrink the workflow—reduce handling, drop the risk of incorrect volume draw or accidental needle sticks, and speed up critical procedures. Our surveys with partner facilities report significant reductions in prep error rates since making the switch to EUCEPT. That translates into concrete time savings, less dose wastage, and higher patient throughput during peak hours. Pharmacists who manage large inventories have also pointed to the clear product coding on each EUCEPT barrel that speeds up stock checks and expiry tracking, supporting visual double-checks in both fast-paced and quiet settings.
Regulations around medical waste grow tighter each year, and manufacturers share the duty of minimizing end-of-life impact. During EUCEPT’s design phase, our materials team mapped out the full waste chain, focusing on reducing plastic in secondary packaging and optimizing syringe barrel construction for compatibility with standard hospital sharps containers. Many “green” solutions pushed onto the market wind up compromising performance or cost, but we select materials with proven chemical resistance and easy incineration profiles. All primary packaging and shipping cartons are fully recyclable, derived from certified, sustainably managed sources.
Inside the plant, we reengineer our own processes to minimize solvent use, recover heat, and reduce rejected lots by as much as possible. Every rejected batch represents not just wasted money, but lost potential for patient care—and opportunity to improve. By tracking process metrics from fill accuracy and force-of-injection tests to bio-burden audits, our manufacturing teams pinpoint root causes and implement tangible fixes. Our top priority remains product safety; at the same time, we keep an eye on the downstream effects so communities and hospital partners handle less medical waste, and environmental exposures fall.
Since rollout, EUCEPT has seen wide adoption in various therapeutic areas, from emergency medicine to chronic disease management. Field feedback drives much of what shifts on our manufacturing floor. For example, after ICU teams reported gloved hands slipping during administration, we modified barrel texture, introducing fine micro-texture bands for secure grip, even with sweaty or wet gloves. Not every other maker will acknowledge small-scale complaints; we have assigned staff whose only job is to analyze supply-chain data and collect user experience stories, then run mini-pilots for iterative product adjustments.
Emergent infectious disease outbreaks provided another real-world test for EUCEPT. Increased demand put pressure on our supply and logistics; we tripled batch QC teams, ran real-time coordination calls between procurement, manufacturing, and hospital liaisons to ensure supply could meet the acute care needs. Those periods exposed areas where other products ran short or required risky repackaging steps. Our prefilled syringes provided fast, clear administration with fewer touchpoints, so overstretched staff didn’t have to pause for reconstitution instructions or extra cleanup after use. Our production planners built a surge protocol to launch extra shifts without compromising traceability or standards—a lesson many competitors learned the hard way.
Anyone with purchasing responsibility in the healthcare sector hears the standard sales lines about volume pricing or slightly better specs. What consistently matters to our customers, and to us, is whether a syringe works when it counts: sharp needles, exact volumes, smooth, consistent force from first plunger press to last, and zero surprises during critical care. Many lower-cost prefilled syringes claim equivalence, but field tests show how micro-burrs on poorly machined needles trigger greater tissue trauma or how inferior plunger assemblies lead to sticky or jumpy motion—even minute differences change outcomes in real settings.
Inside our quality assurance department, each incoming batch of raw material faces spectroscopic and chromatographic testing—not because regulations demand it, but because we’ve seen how trace impurities can later cause discoloration or react with certain APIs. Every step, from barrel dimensions to piston seal force, draws from technical data and actual adverse event reports, so the product doesn’t just pass on paper but proves itself at the bedside. That’s what sets EUCEPT apart: authenticity, openness to critique, and a laser-focus on real-world function, miles past minimum regulatory specs.
Across our customer network, practitioners regularly compare EUCEPT against a mix of legacy and new-market brands. They tell us some differences often cited in theory—like a slightly lower dead volume or a tiny variance in plastic composition—become more pronounced in use. Dead space losses in syringes mean patients sometimes receive less than the intended dose. We revamp assembly tolerances and precision mold tooling to shrink residual volume. Over time, accuracy remains stable, batch after batch, because the process is data-driven.
Some manufacturers put marketing dollars into “innovative” features providers rarely request. Guidance from the field steered us toward incremental changes: de-aeration steps to cut bubbles, backstop lips for better safety against over-insertion, and stronger flange welds to prevent accidental breakage. Competing syringes appearing cheaper may ship with uncertain traceability or have hazy export-document provenance. Every EUCEPT box and file comes with a full supply-chain history, so hospitals can audit sterilization records, component lots, and point-of-origin data to feel sure they’re not being left in the dark. That kind of transparency takes longer, costs more, but builds trust.
The market keeps evolving—with new vaccines, biologics, and complex therapies coming into everyday use. The hard truth is, no single company catches every shift in healthcare. Our approach remains to invest in underlying quality systems, deepen partnerships with health providers, and keep stepping up batch release controls as science advances. We’re directing R&D not into the latest buzzword, but into improving features that actually remove risks and bottlenecks for clinicians: easier-to-handle plungers, lower-breakforce needles, improved lubricants, and automated traceability links to hospital EMR systems.
Real manufacturing always juggles trade-offs—cost, throughput, complexity, waste, demand. By sitting at the intersection of laboratory discipline and hands-on user feedback, EUCEPT continues to improve, not just in specifications, but in the confidence it brings during each injection. As long as practitioners keep sharing insights with us, our duty is to refine, to adapt, and to sustain the trust placed in our products. EUCEPT Prefilled Syringe Inj. stands not as a static, one-time innovation, but as the result of relentless refinement powered by real-world demands and time-earned manufacturing experience.